Biopharma industry experts share their insights on the evolving landscape for infectious disease R&D and how to achieve future success.
Click here to download this Special Report in PDF format.
In Partnership with Cerba Research
Infectious Disease Clinical Trials: Navigating Innovation & Rising Complexity
Listen to this article
In Partnership with Cerba Research
Stay current with trends in infectious disease clinical trials, with fresh insights from a recent roundtable event. Discover how the landscape is evolving and what to expect in the future, with key takeaways from industry experts.
Keep up with the top pharma business news of the week. On the go.
In Partnership with Cerba Research
More from Archive
Optimizing Drug Pipelines With Biophysical Methods”, your view into how using biophysical techniques can enhance and streamline processes throughout the drug discovery and validation cycle.
• By
CEO Paul Stoffels said gaining US clearance for an IND for its novel CAR-T product was demanding, but now opens up a pathway towards a pivotal study starting in 2025.
• By
A final rejection of Leqembi could also spell the same fate for Lilly’s rival drug but public outcry and demand for Alzheimer’s therapies might force the regulator’s hand
• By
GSK will assume full control of mRNA shots in infectious disease, allowing CureVac to cut costs and pivot its research to oncology.
More from Scrip
Sponsored by :
As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.
Primal Pictures
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
Sponsored by
sponsored by